Zyprexa Linked to Diabetes

Zyprexa (generic: olazapine) was approved in 1996 and is part of the class of newer antipsychotic medications called “atypical antipsychotics.” Prescribed to treat the symptoms of schizophrenia, bipolar disorder, and psychotic depression, Zyprexa has become one of the most popular drugs in its class and has been prescribed to 20 million people worldwide.

Zyprexa is manufactured by Eli Lilly & Company and is widely prescribed off-label for disorders such as anxiety disorder, panic disorder, post traumatic stress disorder, and various psychological disorders in children and adolescents.

Zyprexa Side Effects & Complications

Zyprexa has been linked to a high incidence of diabetes, hyperglycemia, pancreatitis and other blood sugar disorders. Many patients on Zyprexa gain weight and develop diabetes soon after beginning the medication. Originally marketed by Eli Lilly as having fewer motor side effects such as tardive dyskenisia than the older antipsychotics such as Haldol, Zyprexa has turned out to be dangerous for many people on the drug. In April 2005, the FDA warned that Zyprexa and other drugs in the class can cause premature death in elderly patients with dementia-related psychosis.

Legal Rights for Zyprexa Patients

  • Did you or a family member take Zyprexa and suffer from diabetes or another blood sugar disorder? If so, you have legal rights. Schizophrenia or bipolar mania patients who have taken Zyprexa are encouraged to contact Mark & Associates, P.C. today for a FREE legal consultation.
  • In June 2005, Eli Lilly & Co. announced a $690 million settlement with 8,000 plaintiffs who were harmed by Zyprexa’s side effects. Our defective drug lawyers may be able to pursue a separate legal claim for damages against Eli Lilly.
  • Mark & Associates, P.C. takes NO legal fees whatsoever unless we win or settle your Zyprexa case.
  • Call 1-866-50-RIGHTS (1-866-507-4448) to speak with a lawyer today, or fill out our case review form and someone will contact you.

Other News

  • Avandia to be removed from Pharmacies

    Avandia the widely prescribed type 2 diabetes drug has been linked to increased cardiovascular risks and the debate has carried on for nearly four years about whether or not the drug should be taken off the market, according to a recent WebMD news report. The FDA issued a safety alert about a possible association between Avandia and increased cardiovascular risks back in 2007. Starting November 2011, the type 2 diabetes drugs Avandia, Avandamet, and Avandaryl will no longer be available [...]

    Read more →

  • Metal Hip Manufactures Asked to Provide Patient Data

    Not too long ago, DePuy Orthopaedics, a division of Johnson & Johnson, recalled two popular hip replacements systems the ASR Hip Resurfacing System and the ASR XL Acetabular System. Depuy said the products were recalled because a high percentage of patients required revision surgery after experiencing pain. Depuy said that it sold 93,000 of these systems before they decided to stop selling them last year. Additionally, dozens of other patients who have had other hip replacements from other manufacturers, such [...]

    Read more →

  • Jury Orders Allergan to Pay $212 Million in Botox Case

    A Virginia man who claimed that injections of the wrinkle-diminishing Botox left him with brain damage has been awarded $212 million by manufacturer Allergan Inc. Douglas Ray Jr. said he was receiving the injections to relieve a hand tremor and writer’s cramp, a report in the Richmond-Times Dispatch said. Ray said that that Allergan failed to warn him that injections could trigger an autoimmune response leading to brain damage. Botox is a purified form of the poison botulinum and is [...]

    Read more →

  • Drug Manufacturers to Discontinue Infant Drops of Key Medicine

    According to a recently released Associated Press news report, Johnson & Johnson and other drug makers of cold and fever medications said that they will discontinue infant drops of medicines containing acetaminophen in an effort to avoid confusion that can lead to dangerous overdoses. The industry association for over-the-counter medicine companies said its members will begin phasing out the liquid drops later this year. After the transition is complete, companies will only sell a single formula for all children under [...]

    Read more →

  • Bisphosphonates Linked to Bone Fractures: Study

    Findings from a new Swedish study reveal that osteoporosis drugs known as bisphosphonates increase the risk of getting unusual thigh bone fractures, as experts have suspected, according to a recent WebMD news article. But these fractures are infrequent and the risk is small the study shows. When correctly prescribed, the overall benefit of the drugs preventing all types of fractures outweighs the risk of getting the unusual fractures, says study researcher Per Aspenberg, MD, PhD, a professor of orthopaedic surgery [...]

    Read more →

  • Babies Heart Defect linked to Crude Oil Chemical Exposure

    According to an April 30, 2001, AFP news report, babies exposed before birth to ethyl benzene, a toxic component in crude oil, may have a higher risk of developing congenital heart disease, US researchers announced. Another chemical used as an industrial metal degreasing agent, trichloroethylene (TCE), also boosted heart risks, said the research to be presented at the Pediatric Academic Societies annual meeting in Denver, Colorado. Congenital heart disease occurs when the heart is malformed before birth, and is the [...]

    Read more →

  • Toyota Announces New Floor Mat Interference Recall

    Once again, Toyota owners are being affected by a new recall due to floor mat interference. Presently, Toyota Motor Corp. is facing hundreds of lawsuits in the United States form vehicle owners or families who suffered personal injuries, wrongful deaths, or suffered financial losses, as a result of sticky gas pedals and floor mat interference, which may causes sudden unexpected acceleration. Since the end of 2009, Toyota has recalled nearly 4 million vehicles in the United States due to sticky [...]

    Read more →

  • Lawsuit over Seat Belts Can Proceed

    According to a recent Reuters news report, The U.S. Supreme Court ruled that federal regulations setting vehicle safety standards do not bar lawsuits seeking damages from automakers for installing lap-only seat belts. The unanimous ruling held that a California lawsuit against Mazda Motor Corp over a fatal 2002 collision involving a 1993 Mazda minivan can proceed. A passenger sitting in a rear seat and wearing a lap-only seat belt was killed. The lawsuit by the family of the passenger claimed [...]

    Read more →